Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product manufacturing. Forma was established following BioSelective Capital’s acquisition of BioDuro. The deal included two GMP facilities in Irvine, California. Both have a long-standing regulatory track record supporting clinical and commercia...